insulin, aspart, human 100 UNT/ML per 3 ML Pen Injector

RxCUI: 1653202
RxNorm name: insulin, aspart, human 100 UNT/ML per 3 ML Pen Injector
Display name: insulin, aspart, human 100 UNT/ML per 3 ML Pen Injector
Full name: insulin, aspart, human 100 UNT/ML per 3 ML Pen Injector
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:54

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
020986	Novolog	insulin aspart	351(a)	Rx	2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Insulin Aspart	INSULIN ASPART	REMEDYREPACK INC.	b3d77cb0-cd47-441f-8f54-5329c655da9c	2026-01-14	Warnings, Adverse reactions	Exact identifier rxcui: 1653202
Insulin Aspart	INSULIN ASPART	A-S Medication Solutions	c3e4c46e-5211-4f05-b7ab-1e9ad270876b	2024-09-11	Warnings, Adverse reactions	Exact identifier rxcui: 1653202
NOVOLOG	INSULIN ASPART	A-S Medication Solutions	13891e5a-e57a-46e8-911c-2f680352b52b	2023-12-15	Warnings, Adverse reactions	Exact identifier rxcui: 1653202
NOVOLOG	INSULIN ASPART	A-S Medication Solutions	e172b4f8-9b25-4019-8e09-afc10b2f30c9	2023-12-09	Warnings, Adverse reactions	Exact identifier rxcui: 1653202
Insulin Aspart	INSULIN ASPART	Novo Nordisk Pharma, Inc.	bee5b358-c863-420b-be73-ced2e920c499	2023-02-28	Warnings, Adverse reactions	Exact identifier rxcui: 1653202
Insulin Diluting Medium for NovoLog	WATER INJECTION	Novo Nordisk	3a1e73a2-3009-40d0-876c-b4cb2be56fc5	2023-02-28	Warnings, Adverse reactions	Exact identifier rxcui: 1653202

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 7 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
3a1e73a2-3009-40d0-876c-b4cb2be56fc5	insulin aspart 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin aspart, human 100 UNT/ML Pen Injector [SCD] · insulin, aspart, human 100 UNT/ML per 3 ML Pen Injector [SY]	3	34	These highlights do not include all the information needed to use NOVOLOG safely and effectively. See full prescribing information for NOVOLOG. NOVOLOG ® (insulin aspart) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2000	20230228
e172b4f8-9b25-4019-8e09-afc10b2f30c9	insulin aspart 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin aspart, human 100 UNT/ML Pen Injector [SCD] · insulin, aspart, human 100 UNT/ML per 3 ML Pen Injector [SY]	3	28	These highlights do not include all the information needed to use NOVOLOG safely and effectively. See full prescribing information for NOVOLOG. NOVOLOG ® (insulin aspart) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2000	20231209
c3e4c46e-5211-4f05-b7ab-1e9ad270876b	insulin aspart 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin aspart, human 100 UNT/ML Pen Injector [SCD] · insulin, aspart, human 100 UNT/ML per 3 ML Pen Injector [SY]	3	9	These highlights do not include all the information needed to use INSULIN ASPART safely and effectively. See full prescribing information for INSULIN ASPART. INSULIN ASPART injection, for subcutaneous or intravenous use Initial U.S. Approval: 2000 This product is NovoLog (insulin aspart).	20240911
13891e5a-e57a-46e8-911c-2f680352b52b	insulin aspart 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin aspart, human 100 UNT/ML Pen Injector [SCD] · insulin, aspart, human 100 UNT/ML per 3 ML Pen Injector [SY]	3	6	These highlights do not include all the information needed to use NOVOLOG safely and effectively. See full prescribing information for NOVOLOG. NOVOLOG ® (insulin aspart) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2000	20231215
b3d77cb0-cd47-441f-8f54-5329c655da9c	insulin aspart 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin aspart, human 100 UNT/ML Pen Injector [SCD] · insulin, aspart, human 100 UNT/ML per 3 ML Pen Injector [SY]	3	5	These highlights do not include all the information needed to use INSULIN ASPART safely and effectively. See full prescribing information for INSULIN ASPART. INSULIN ASPART injection, for subcutaneous or intravenous use Initial U.S. Approval: 2000 This product is NovoLog (insulin aspart).	20260114
bee5b358-c863-420b-be73-ced2e920c499	insulin aspart 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin aspart, human 100 UNT/ML Pen Injector [SCD] · insulin, aspart, human 100 UNT/ML per 3 ML Pen Injector [SY]	3	5	These highlights do not include all the information needed to use INSULIN ASPART safely and effectively. See full prescribing information for INSULIN ASPART. INSULIN ASPART injection, for subcutaneous or intravenous use Initial U.S. Approval: 2000 This product is NovoLog (insulin aspart).	20230228
cd88e313-6193-4413-beff-7d955580060d	insulin aspart 100 UNT/ML in 3 ML Pen Injector [PSN] · 3 ML insulin aspart, human 100 UNT/ML Pen Injector [SCD] · insulin, aspart, human 100 UNT/ML per 3 ML Pen Injector [SY]	3	1	These highlights do not include all the information needed to use NovoLog safely and effectively. See full prescribing information for NovoLog. NovoLog ® (insulin aspart [rDNA origin] injection) solution for subcutaneous use Initial U.S. Approval: 2000	20130723